We read with great interest the article by Lavienraj Premraj et al. recently published in your
journal [1]. This study reported the results of a systematic review and meta-analysis …

The management and degree of severity of neurological manifestations during the active
phase of COVID-19 and beyond is currently a challenge. Especially because of the indirect …

Objective: To determine the prevalence of neurological and neuropsychiatric symptoms
reported 12 weeks (3 months) or more after acute COVID-19 onset in adults. Background …

Importance Neurological and neuropsychiatric symptoms that persist or develop three
months after the onset of COVID-19 pose a significant threat to the global healthcare system …

Introduction The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can affect
multiple organs. Reports of persistent or newly emergent symptoms, including those related …

Our aim was to determine the frequency and characteristics of neurological post-COVID-19
syndrome and the diagnostic and therapeutic measures that were used for the treatment of …

COVID-19 IS CAUSED by SARS-CoV-2, which primarily targets angiotensin converting
enzyme-2 (ACE2) receptors on cells of the respiratory system and induces an immediate …

Background and Objectives: Neurological and psychiatric symptoms are frequent in patients
with post-COVID-19 syndrome (PCS). Here, we report on the clinical presentation of the first …

Background Covid-19 became a global pandemic in 2019. Studies have shown that
coronavirus can cause neurological symptoms, but clinical studies on its neurological …

Purpose We report our single-center experience on the neurological manifestations of long
COVID. Patients and Methods This is a retrospective observational study. All consecutive …